Dr. Margaret A. Chinbuah
Margaret Amanua Chinbuah, Ph.D., M.P.H., MbCHB, is based in Ghana and currently serves as Newborn Care Technical Advisor for PATH, an organization leading global health innovations especially as it applies to women and children. Dr. Chinbuah has worked as a medical officer providing clinical care in Ghana and has been responsible for managing several implementation studies supporting various programs the Child Health program, the National HIV/AIDS, Malaria and TB programs. She is directly responsible for the technical component of the “Making Every Baby Count Initiative” (MEBCI) . In her role as Newborn Care Advisor, she is deeply involved with the development of policies and guidelines that impact the mother and child including the development of guidelines for Kangaroo Mother Care in Ghana, Child Health guidelines, sick newborn monitoring Charts etc. Dr Chinbuah received her medical degree from the University of Ghana Medical School, a Masters of Public Health from the School of Public Health, University of Ghana. She obtained a Masters of Health Science, specialization in Epidemiology from the Erasmus University in Rotterdam, Netherlands and a PhD in epidemiology from the University of Amsterdam, Netherlands. Dr Chinbuah is fluent in English, is a member of the Ghana College of Surgeons and Physicians, the National Newborn Subcommittee, the National Child Health Committee, the Chlorhexidine Study group etc. She has co-authored several publications, made many presentations at national and global conferences and a resource person for various the National Task Teams.
Dr. Mario R. Dal Poz
Mario Roberto Dal Poz, Ph.D., M.D., M.S., is a Brazilian based physician and researcher who is a full professor at the Social Medicine Institute of the University of the State of Rio de Janeiro, the editor-in-chief of the Human Resources for Health journal. He formerly worked as coordinator of the “Human Resources for Health” department at the World Health Organization. Dr. Dal Poz was invited to deliver a Regency Lecture on the “Global Response to the Health Workforce Crisis” at the Global Center for Health Economics and Policy Research of the University of California in 2008 and was awarded the Oswald Cruz Gold Merit Medal from the Brazilian President for his contributions to public health. He has published numerous books, as well as articles and commentaries in leading medical journals such as The Lancet, PLOS and Health Affairs. Dr. Dal Poz obtained his medical degree in 1975 from Rio de Janeiro State University, followed by a Master’s in social medicine in 1981, and a doctorate in public health in 1996 from the Oswaldo Cruz Foundation. He receives research grants from the National Research Council (CNPq) and the Research Foundation of Rio de Janeiro (FAPERJ).
Dr. Ashish K. Jha
Ashish Jha, M.D., M.P.H, is the K.T. Li Professor of Global Health at Harvard University and the Director of the Harvard Global Health Institute. He is a practicing General Internist and also Professor of Medicine at Harvard Medical School. Dr. Jha received his M.D. from Harvard Medical School and then trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women’s Hospital at Harvard Medical School and received his M.P.H. from Harvard T.H. Chan School of Public Health. His research endeavors focus on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies. Dr. Jha has published over two hundred various papers in prestigious journals and heads a personal blog which focuses on using statistical data research to improve health quality. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine.
Ms. Sheila T. Leatherman
Sheila Leatherman, CBE, Hon FRCP is a Professor, at the Gillings School of Global Public Health, University of North Carolina. She conducts research and policy analysis internationally focusing on quality of care, health systems reform and methodologies for evaluating the performance of health care systems. In the international field of health care quality and health systems strengthening, she has advised and assisted in the development of national programs and strategies in countries such as the US, UK, Sudan, South Africa, Singapore, Afghanistan, Nigeria, Saudi Arabia, Mexico, Canada and Ethiopia. Ms. Leatherman is the lead adviser for the 5-year WHO National Quality Policy and Strategy initiative supporting low- and middle-income countries in designing and implementing national quality strategies (2015-2019). She is both a principle investigator and adviser for research and implementation projects in multiple countries, and she contributes to multiple humanitarian and global health INGOs, including serving as the Quality Adviser for Doctors Without Borders/OCP. In 2002 she was elected to the US National Academy of Sciences Institute of Medicine and in 2006 she was made an Honorary Fellow of the Royal College of Physicians. In 2007, she was awarded the honor of Commander of the British Empire (CBE) by Queen Elizabeth for her work over the past decade in the National Health Service. Ms. Leatherman has authored numerous articles and books. Her broad background in health care management in US state and federal health agencies includes the role of chief executive of an HMO and a senior executive of United Health Group, where she founded and directed a research center.
Dr. Tianjing Li
Tianjing Li, M.D., M.H.S., Ph.D., serves as Assistant Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health (JHBSPH) and as the Associate Director for the US Cochrane Center, one of the 14 centers around the world that facilitate the work of the Cochrane Collaboration. The aim of Dr. Li’s research is to develop, evaluate, and disseminate efficient methods for comparing healthcare interventions and to provide sound evidence for decision making. The focus areas of her research include methodologies for systematic reviews, network meta-analysis, randomized controlled trials, comparative effectiveness research, and patient-centered outcomes research. Dr. Li’s accomplishments and research efforts earned her the inaugural Society for Research Synthesis Methodology Early Career Award in 2016. Dr. Li serves as Editor-in-Chief for journal Trials and Associate Editor for journal Ophthalmology. She has received grant support from the National Eye Institute, Patient-Centered Outcomes Research Institute, Food and Drug Administration, Agency for Healthcare Research and Quality. Dr. Li continues to teach graduate level courses at the JHBSPH on clinical trials, systematic review, epidemiology, biostatistics, advanced doctoral seminars, and grant writing.
Dr. Vincent Okungu
Vincent Okunugu, M.A., M.P.H., Ph.D., is a researcher at PharmAccess Foundation and adjunct faculty at the Institute of Healthcare Management, Strathmore University. He was previously a Research Officer and Team Leader at the KEMRI CDC and a Research Officer, Research Assitant, and Ph.D. Fellow at KEMRI the Wellcome Trust Research Program in Kenya. Hi research interests focus on health care financing and universal coverage policy, costing and cost-effectiveness analysis, global health, and healthcare quality, equity and access. His work has been published numerous times. He currently has two journal papers under review addressing healthcare in the informal sector. He has consulted for organizations such as USAID, Palladium Group and the Fed Hollows Foundation and also for the Kenya Ministry of Health. Dr. Okungu received his Masters in Medical Anthropolgy in 2003 from the University of Nairobi, his Masters in Public Health in Health Economics in 2010 from the University of Cape Town, and doctorate in Health Economics/Financing from the University of Cape Town in 2015.
Dr. Neeraj Sood
Neeraj Sood, Ph.D, is Professor and Vice Dean for Research at the University of Southern California (USC) Sol Price School of Public Policy. He is also a faculty member at USC Schaeffer Center and research associate at the National Bureau of Economic Research. He serves on the editorial board of Journal of Health Economics, Health Services Research, and Forum for Health Economics and Policy, and is on the board of directors of the American Society of Health Economists. His prior work focuses on the economics of innovation, HIV/AIDS, health care financing, and global health. His research has been published in several peer-reviewed journals and books including leading journals in economics, medicine and health policy. He has testified frequently on health policy issues and his work has also been featured in several media outlets including the New York Times, Washington Post, U.S. News and World Report, and Scientific American. Dr. Sood was the finalist for the 16th and 21st Annual NIHCM Health Care Research Award, recognizing outstanding research in health policy. He was also the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy. Prior to joining USC, Dr. Sood was a senior economist at the RAND Corporation and Professor at the Pardee RAND Graduate School.
Dr. Jeanette Vega
Jeanette Vega, M.D, M.P.H, Ph.D, is based in Santiago, Chile as the General Director of the National Chilean Public Health Insurance Agency (FONASA) since March 2014. Reigning 20 years of experience in international health, Dr. Vega’s expertise lies in social determinants of health, healthy equity, and health systems. Dr. Vega began her career as a medical doctor practicing Family Medicine and has a master’s degree in Public Health from the Universidad de Chile and a Ph.D. in Public Health from the University of Illinois at Chicago. Since obtaining her degrees she has served in prominent public health leadership roles, such as Vice Minister of health in Chile, Director of the Center of Public Health Policy at the Universidad del Desarrollo and Director at the World Health Organization in Geneva where she headed the organization’s health equity agenda. In 2012, Dr. Vega joined The Rockefeller Foundation to lead its health-related work, including heading their Transforming Health Systems Initiative.
Dr. Marcel Yotebieng
Marcel Yotebeing, M.D., M.P.H., Ph.D., has worked in multiple countries in Sub-Saharan Africa as clinician, public health practitioner, and researcher. He has served as Principal Investigator on multiple grants funded by the National Institute of Health (two RO1s), the Gates foundation, and the World Health Organization. He has also served as co-investigator on large cooperative agreements (UO1 or U2) from NIH and CDC. This funding has allowed him and his collaborators to build strong research infrastructures in the Democratic Republic of Congo (DRC – a centrally located office with >20 full-time staff, cars, freezers, all supporting ongoing data collection in 106 health facilities across the entire province of Kinshasa). His work has informed national and international guidelines on tuberculosis management and treatment of HIV in children. Results from one of his recently completed trial had led to calls for the World Health Organization to revisit its almost three decades’ policy on breastfeeding promotion. His expertise is well recognized at both the national and the international levels. He has served as member of the scientific committee that advise the National TB Program in the DR Congo on guidelines since 2011. He has been invited to chair a discussion section at the Conference on Retroviruses and Opportunistic Infections (CROI) or to participate on panel discussions at other regional and international meetings. As the lead for the pediatric work for the Central Africa International Epidemiologic Database to Evaluate AIDS, he has been a key member of the Collaborative Initiative for Pediatric HIV Education and Research (CIPHER) Cohort Collaboration since its inception. Recently, he was invited to join the Global Burden of Disease Network and more importantly, he has been nominated by NIH to serve on the ad hoc committee being convened by the U.S. National Academies of Sciences, Engineering, and Medicine to study particular prospects for improving health care quality globally.